Do you LISTEN TO YOUR HEART? It could save your life! As part of World Heart Rhythm Week (7th-13th June), a national charity for heart rhythm disorders, Arrhythmia Alliance, is calling for everyone to ‘listen to their heart’ to get to know the rhythm and not just the heart rate. Over 100,000 people each year die suddenly […]
Read More… from LISTEN TO YOUR HEART? It could save your life!
DETECT AF at vaccine centres: Success of Arrhythmia Alliance Detection of AF at COVID-19 vaccination centres scheme shows value of using every opportunity to DETECT AF in people aged 65 or older. A scheme by Arrhythmia Alliance to DETECT atrial fibrillation (AF) — the most common type of arrhythmia (heart rhythm disorder) and a major […]
Blood clot-busting nanocapsules could reduce existing treatment’s side effects: Imperial researchers have designed drug delivery nanocapsules that could reduce the side effects of a major blood clot dissolving drug. Tested on human blood in the lab, the selective nanocapsules could reduce the side effects of a major blood clot dissolving drug, which include bleeding on […]
Read More… from Nanocapsules could reduce existing treatment’s side effects
Funding boost gives hope to vulnerable Australian cardiac patients: A Curtin University research team has been awarded almost $1.5million in Federal Government funding to coordinate Australian trials of a high-flow oxygen delivery strategy to reduce complications for vulnerable cardiac surgery patients, particularly Aboriginal and Torres Strait Islander people. The project, led by Associate Professor Edward […]
Read More… from Funding boost for vulnerable Australian cardiac patients
Results of the COLCORONA study published in The Lancet Respiratory Medicine – Colchicine could be considered as a treatment for non-hospitalized patients diagnosed with COVID-19 by PCR test and at risk of complications: The Montreal Heart Institute (MHI) announces that the COLCORONA study results are published in The Lancet Respiratory Medicine. The article, which is […]
Antifibrotic drugs offer hope to thousands of patients who are living with a condition that has a worse outcome than most cancers. · Action for Pulmonary Fibrosis (APF) is delighted to announce their campaign, backed by patients, families and medical experts, to end the inhumane restrictions on life-extending antifibrotic drugs has been successful. · Today […]
Read More… from Victory for thousands of terminally ill patients
Long working hours increasing deaths from heart disease and stroke: WHO, ILO: Long working hours led to 745 000 deaths from stroke and ischemic heart disease in 2016, a 29 per cent increase since 2000, according to the latest estimates by the World Health Organization and the International Labour Organization published in Environment International. In a […]
Mouse studies find sugar-free energy drinks just as harmful: Two Curtin research studies have found the excessive consumption of energy drinks, even sugar-free varieties, can cause significant damage to brain cells and increase the risks of heart disease, stroke and type 2 diabetes. The research investigated links between the chronic consumption of energy drinks and […]
Read More… from Mouse studies find sugar-free energy drinks just as harmful
Future of lung disease care ‘at risk’ due to workforce shortages and backlog from COVID-19: Staffing shortages are impacting diagnosis, treatment, and care of people with lung disease, according to the Taskforce for Lung Health The Taskforce for Lung Health, a collaboration of over 30 charities, organisations and patients looking to improve lung health in England, […]
Researchers at the University of Eastern Finland have discovered previously unknown non-coding RNAs (ncRNAs) involved in regulating the gene expression of vascular endothelial growth factors (VEGF), the master regulators of angiogenesis. The study, conducted by the research groups of Associate Professor Minna Kaikkonen-Määttä and Academy Professor Seppo Ylä-Herttuala, provides a better understanding of the complex […]
Read More… from Novel non-coding RNAs regulating blood vessel formation